
Simulations Plus Invests in Clinical Development Technology Company Nurocor
RESEARCH TRIANGLE PARK, N.C., July 15, 2025 — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced […]